These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8881841)

  • 1. Thrombolytic therapy for evolving myocardial infarction needs an approach that integrates benefit and risk.
    Arnold AE; Simoons ML
    Eur Heart J; 1995 Nov; 16(11):1502-9. PubMed ID: 8881841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument.
    Selker HP; Griffith JL; Beshansky JR; Schmid CH; Califf RM; D'Agostino RB; Laks MM; Lee KL; Maynard C; Selvester RH; Wagner GS; Weaver WD
    Ann Intern Med; 1997 Oct; 127(7):538-56. PubMed ID: 9313022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining the risk-benefit equation for thrombolysis: how to identify the low risk patient before administering thrombolytic therapy.
    Nidorf M; Parsons R; Thompson P; Jamrozik K; Hobbs M
    Aust N Z J Med; 1998 Aug; 28(4):525-8. PubMed ID: 9777133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailored thrombolytic therapy. A perspective.
    Simoons ML; Arnold AE
    Circulation; 1993 Dec; 88(6):2556-64. PubMed ID: 8252667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarction.
    Hillegass WB; Jollis JG; Granger CB; Ohman EM; Califf RM; Mark DB
    Am J Cardiol; 1994 Mar; 73(7):444-9. PubMed ID: 8141084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial hemorrhage after thrombolytic therapy. A perspective.
    Simoons ML; de Jaegere P; van Domburg R; Boersma E
    Z Kardiol; 1993; 82 Suppl 2():153-6. PubMed ID: 8328195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated gain in life expectancy. A simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction.
    Boersma H; van der Vlugt MJ; Arnold AE; Deckers JW; Simoons ML
    Eur Heart J; 1996 Jan; 17(1):64-75. PubMed ID: 8682132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
    Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L
    N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimising thrombolytic therapy in elderly patients with acute myocardial infarction.
    Verstraete M; Collen D
    Drugs Aging; 1996 Jan; 8(1):17-22. PubMed ID: 8785464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Expected infarct size without thrombolysis', a concept that predicts immediate and long-term benefit from thrombolysis for evolving myocardial infarction.
    Arnold AE; Simoons ML
    Eur Heart J; 1997 Nov; 18(11):1736-48. PubMed ID: 9402448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrinolysis as a therapeutic option in acute ST-elevation myocardial infarction].
    Arntz HR; Mochmann HC
    Dtsch Med Wochenschr; 2010 Nov; 135(47):2372-4. PubMed ID: 21082532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-benefit of thrombolysis.
    Simoons ML
    Cardiol Clin; 1995 Aug; 13(3):339-45. PubMed ID: 7585771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of reperfusion therapy for individual patients with evolving myocardial infarction.
    Eur Heart J; 1997 Sep; 18(9):1371-81. PubMed ID: 9458441
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
    Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
    N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT patterns of intracranial hemorrhage complicating thrombolytic therapy for acute myocardial infarction.
    Uglietta JP; O'Connor CM; Boyko OB; Aldrich H; Massey EW; Heinz ER
    Radiology; 1991 Nov; 181(2):555-9. PubMed ID: 1924804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies.
    Grines CL; DeMaria AN
    J Am Coll Cardiol; 1990 Jul; 16(1):223-31. PubMed ID: 2193050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic therapy.
    Li X; Li J; Masoudi FA; Spertus JA; Lin Z; Krumholz HM; Jiang L;
    BMJ Open; 2016 Oct; 6(10):e013355. PubMed ID: 27798032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of bivalirudin in percutaneous coronary intervention following thrombolytic therapy.
    Sardi GL; Lindsay J; Waksman R
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):614-20. PubMed ID: 22581418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intracranial hemorrhage following second thrombolytic treatment of myocardial reinfarction].
    Valentín Segura V; Valls Grima F; Broch Porcar MJ; Miralles Serrano L; Olivares Toledo D; Alvarez Cebrián F
    Rev Esp Cardiol; 1994 Dec; 47(12):836-8. PubMed ID: 7855379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital major bleeding and its clinical relevance in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Boden H; Velders MA; van der Hoeven BL; Cannegieter SC; Schalij MJ
    Am J Cardiol; 2013 Nov; 112(10):1533-9. PubMed ID: 23953696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.